| NOVO-NORDISK AS B DK 0,1 |
| Dänemark |
| Gesundheit |
| DK0062498333 / A3EU6F |
| NOV (Frankfurt) |
| FRA:NOV, ETR:NOV, NOV:GR |
| - |
| https://www.novonordisk.c.. |
|
Novo Nordisk A/S is a global pharmaceutical company specializing in research, development, and manufacturing of treatments for serious chronic diseases. Founded through the 1989 merger of Danish insulin pioneers Nordisk Insulaboratorium and Novo Tera..
>Volltext.. |
| 170498.01 Mio. EUR |
| 187160.5 Mio. EUR |
| 43696.84 Mio. EUR |
| 22740.62 Mio. EUR |
| 16257.28 Mio. EUR |
| 3.66 EUR |
| 19513.21 Mio. EUR |
| 2816.3 Mio. EUR |
| 13020.01 Mio. EUR |
| 0.1 |
| 7.76% |
| 16.17% |
| 1.57 EUR |
| 4.14% |
| 4.08% |
| 27.03.26 - 1.064076€ 15.08.25 - 0.502445€ >weitere anzeigen... |
| - |
| NOVO NORDISK, NOVONORDISK |
| 14.06.26 |
|